Skip to main navigation

Skip to content
Skip to primary sidebar
Skip to footer

240.243.1201
info@glycomimetics.com

Careers
Contact Us

Investor Relations

About Us
Patients
- Clinical Trials
- Expanded Access
Pipeline
- Programs
- Therapeutic Focus
  - Acute Myeloid Leukemia (AML)
  - Sickle Cell Disease
Technology & Publications
Collaborations
Investors

PRESS RELEASES

Investor Relations

About Us
Patients
- Clinical Trials
- Expanded Access
Pipeline
- Programs
- Therapeutic Focus
  - Acute Myeloid Leukemia (AML)
  - Sickle Cell Disease
Technology & Publications
Collaborations
Investors

PRESS RELEASES

Year

April 12, 2019

GlycoMimetics Announces Plans to Initiate Breast Cancer Trial to Evaluate GMI-1359

April 4, 2019

GlycoMimetics to Present at Upcoming Investor Conferences

March 7, 2019

GlycoMimetics to Present at the Cowen and Company 39th Annual Health Care Conference 2019

March 6, 2019

GlycoMimetics Reports Fourth Quarter and Year-End 2018 Results

March 5, 2019

GlycoMimetics Announces Transition Plan for Board of Directors

February 27, 2019

GlycoMimetics to Report Fourth Quarter and Year-End 2018 Financial Results on March 6, 2019

Shareholder Tools

Print

Print
Printed Materials

Printed Materials
Email Alerts

Email Alerts
Downloads

Downloads
RSS

RSS
Search

Search

Footer

Questions?

Contact GlycoMimetics Today

Get in Touch

©2019 GlycoMimetics All rights reserved. Website Design & Development: Graphic Beans

Site Map | Terms of Use | Privacy | Contact Us